MedUniverse helps life sciences companies create HCP engagement strategies
Access to HCPs is becoming more and more restricted, limiting the industry’s ability to raise awareness about treatments, and help prescribers to identify the right patients for their products.
The resulting lack of commercial/medical HCP engagement has a negative impact on both patient outcomes and access to novel treatments.
To bridge the gap between industry and HCPs,
MedUniverse has developed an engagement methodology that reconciles industry objectives and HCP needs